• $.$$


Naturally Splendid Provides Update for Phase 2 COVID 19 Clinical Trial

May 21, 2020-09:10 AM EDT

Vancouver, British Columbia - TheNewswire - May 21, 2020 - Naturally Splendid Enterprises Ltd. ("Naturally Splendid", "NSE" or "the Company") (FRANKFURT:50N) (TSXV:NSP)(OTC:NSPDF) is pleased to provide the following update regarding preparation for a phase 2 clinical trial treatment for COVID 19. (See news release dated, May 19, 2020) Health Canada has performed an initial review of data for a Clinical Trial Application (CTA) and have advised that the Biologic Division within the Health Canada Office of Regulatory Affairs Biologicand Radiopharmaceutical Drugs Directorate is the appropriate channel to which the completed CTA can continue its processing. This significant designation creates a clear path for the CTA to proceed.

READ FULL NEWS

IIROC Trading Resumption – NSP

May 19, 2020-01:37 PM EDT

Canada NewsWire VANCOUVER, May 19, 2020 VANCOUVER, May 19, 2020 /CNW/ - Trading resumes in: Company: Naturally Splendid Enterprises Ltd. TSX-Venture Symbol: NSP (all issues) Resumption (ET): 14:00

READ FULL NEWS

Naturally Splendid Announces LOI for Joint Venture with Biologic Pharmamedical Research for COVID 19 Clinical Trial

May 19, 2020-01:20 PM EDT

Vancouver, British Columbia - TheNewswire - May 19, 2020 - Naturally Splendid Enterprises Ltd. ("Naturally Splendid", "NSE" or "the Company") (FRANKFURT:50N) (TSXV:NSP)(OTC:NSPDF) is pleased to announce that it has entered into a Letter of Intent with Vancouver based Biologic Pharmamedical Research ("Biologic") to form a joint venture for the purpose of further developing and pursuing phase 2 clinical studies, utilizing one of Biologic's patented technologies as a candidate for a potential COVID 19 treatment. The joint venture entity will be granted certain rights from Biologic's patents as it relates to applications for treating COVID 19 infections. The categories to be licensed will include, but are not limited to COVID 19 applications, as well as additional respiratory indications that may arise out of the fast-tracked phase 2 clinical trial.

READ FULL NEWS

IIROC Trading Halt – NSP

May 19, 2020-12:10 PM EDT

Canada NewsWire VANCOUVER, May 19, 2020 VANCOUVER, May 19, 2020 /CNW/ - The following issues have been halted by IIROC: Company: Naturally Splendid Enterprises Ltd. TSX-Venture Symbol: NSP (All Issues) Reason: At the Request of the Company Pending News

READ FULL NEWS
[stock-quotes-list]
?
This website collects data via Google Analytics. Click here to opt in. Click here to opt out.
×